TRIM21 also influences T cell differentiation by targeting IRF3 to inhibit ex vivo Th1 and Th17 differentiation in CD4+ T cells isolated from inflammatory bowel disease (IBD) patients25. The gene discussed is CD4; the disease is inflammatory bowel disease.